Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosus

Keyphrases

• Tolerability 100%
• Mycophenolate Mofetil 100%
• Systemic Lupus Erythematosus 100%
• Adverse Events 50%
• Clinical Improvement 20%
• Systemic Lupus Erythematosus Patient 20%
• Drug Discontinuation 20%
• Prednisone 10%
• Dosing Schedule 10%
• Baseline Data 10%
• Hospitalization 10%
• Clinical Response 10%
• Disease Activity 10%
• Leukopenia 10%
• Baseline Characteristics 10%
• Kaplan-Meier Estimator 10%
• Dose Adjustment 10%
• Lack of Efficacy 10%
• Characteristic Response 10%
• SLE Disease Activity Index (SLEDAI) 10%
• Gastrointestinal Side Effects 10%
• Flexible Dosing 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Tolerability 100%
• Mycophenolate Mofetil 100%
• Systemic Lupus Erythematosus 100%
• Adverse Event 60%
• Infection 10%
• Disease Activity 10%
• Prednisone 10%
• Leukopenia 10%

Immunology and Microbiology

• Systemic Lupus Erythematosus 100%
• Mycophenolate Mofetil 100%
• Infectious Disease 10%
• Prednisone 10%
• Infection 10%